Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Gregory Obara

1PUBLICATIONS

11CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Apr 23, 2024

A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma.

James Brugarolas, Gregory Obara, Kathryn E Beckermann

Pageof 1

Frequent Collaborators

1 joint publications

James Brugarolas

1 joint publications

Kathryn E Beckermann

1 joint publications

Brian Rini

1 joint publications

Elaine T Lam

1 joint publications

James Hamilton

1 joint publications

Thomas Schluep

1 joint publications

Min Yi

1 joint publications

So Wong

1 joint publications

Zhongping Lily Mao

1 joint publications

Erick Gamelin

Frequent Collaborators

1 joint publications

James Brugarolas

1 joint publications

Kathryn E Beckermann

1 joint publications

Brian Rini

1 joint publications

Elaine T Lam

Top Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on : Apr 03, 2018

See more related videos

Top Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on : Apr 03, 2018

See more related videos